8:34 AM ET
10-Q
Financial Results
CytoDyn Q1 2026 Results: Net Loss of $19.9M, Loss Widens
CytoDyn reported a net loss of $19.9 million for the quarter ended August 31, 2026, significantly higher than the $5.5 million loss in the prior year due to a $12.3 million loss on note extinguishment. The company continues to express substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $950.4 million.
- Key figure
- Net loss $19.9M